✦ LIBER ✦

Erratum to: Phase I study of PF-04691502, a small-molecule, oral, dual inhibitor of PI3K and mTOR, in patients with advanced cancer

✍ Scribed by Britten, Carolyn D.; Adjei, Alex A.; Millham, Robert; Houk, Brett E.; Borzillo, Gary; Pierce, Kristen; Wainberg, Zev A.; LoRusso, Patricia M.

Book ID: 121550658
Publisher: Springer US
Year: 2014
Tongue: English
Weight: 67 KB
Volume: 32
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-014-0069-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of PF-04691502, a small-mo

Phase I study of PF-04691502, a small-molecule, oral, dual inhibitor of PI3K and mTOR, in patients with advanced cancer

✍ Britten, Carolyn D.; Adjei, Alex A.; Millham, Robert; Houk, Brett E.; Borzillo, 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 286 KB

383 First-in-human study of PF-04691502,

383 First-in-human study of PF-04691502, a small molecule oral dual inhibitor of PI3K and mTOR in patients with advanced cancer: Preliminary report on safety and pharmacokinetics

✍ C.D. Britten; A.A. Adjei; R. Millham; B. Houk; Z.A. Wainberg; T. Guthrie; G. Dy; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 130 KB

358 A Multi-arm Phase 1 Dose Escalation

358 A Multi-arm Phase 1 Dose Escalation Study of Safety, Pharmacokinetics, and Pharmacodynamics of the Dual PI3K/mTOR Inhibitors PF-04691502 (oral) and PF-05212384 (IV) in Combination with the MEK Inhibitor PD-0325901 or Irinotecan in Patients with Advanced Cancer

✍ Britten, C.; Wainberg, Z.; Tabernero, J.; Alsina Maqueda, M.; Leong, S.; Sessa, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

387 First-in-human study of PF-05212384,

387 First-in-human study of PF-05212384, a small molecule intravenous dual inhibitor of PI3K and mTOR in patients with advanced cancer: preliminary report on safety and pharmacokinetics

✍ G.I. Shapiro; J. Molina; J. Bendell; I. Braña; J. Spicer; E. Kwak; S. Pandya; R. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

366 Phase I Dose-escalation Study of the

366 Phase I Dose-escalation Study of the Oral Dual MTOR/PI3K Inhibitor BEZ235, Solid Dispersion System (SDS) Sachet Formulation, in Patients with Advanced Solid Tumors

✍ Ahnert, J. Rodon; Burris, H.A.; Schellens, J.H.M.; Schuler, M.; Goodman, O.; Bri 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Phase I dose-escalation and -expansion s

Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors

✍ Rodon, Jordi; Braña, Irene; Siu, Lillian L; Jonge, Maja J; Homji, Natasha; Mills 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 925 KB